Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?-Reference-Cited by-同舟云学术

Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?

Published:2017-07-06 Issue:11 Volume:40 Page:903-909
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Nehme Ali,Zibara Kazem

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

https://www.nature.com/articles/hr201765.pdf

Reference91 articles.

1. Lackland DT . Hypertension: joint national committee on detection, evaluation, and treatment of high blood pressure guidelines. Curr Opin Neurol 2013; 26: 8–12.

2. McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A, Estrella-Holder E, Giannetti N, Grzeslo A, Harkness K, Howlett JG, Kouz S, Leblanc K, Mann E, Nigam A, O’Meara E, Rajda M, Steinhart B, Swiggum E, Le VV, Zieroth S, Arnold JMO, Ashton T, D’Astous M, Dorian P, Haddad H, Isaac DL, Leblanc M-H, Liu P, Ross HJ, Sussex B . The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 2013; 29: 168–181.

3. Bohlender J, Ménard J, Ganten D, Luft FC . Angiotensinogen concentrations and renin clearance implications for blood pressure regulation. Hypertension 2000; 35: 780–786.

4. Jeunemaitre X . Genetics of the human renin angiotensin system. J Mol Med (Berl) 2008; 86: 637–641.

5. Swales JD, Thurston H . Generation of angiotensin II at peripheral vascular level: studies using angiotensin II antisera. Clin Sci Mol Med 1973; 45: 691–700.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virus;2024-01-17

2. Monte Carlo Optimization Based QSAR Modeling of Angiotensin II Receptor Antagonists;Acta Chimica Slovenica;2023-09-20

3. End-Organ Damage in Hypertension: An Insight on a Differentiated Outpatient Consultation;Cureus;2023-09-12

4. Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events;European Heart Journal Open;2023-09

5. Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors;International Journal of Molecular Sciences;2023-01-23